Business Context and Reporting Period
This Form 8-K is filed by Landec Corporation (not Lifecore Biomedical, Inc., as indicated in the metadata request) on January 4, 2017. The report announces the consolidated financial results for the second quarter of fiscal year 2017, which ended on November 27, 2016.
Key Financial Metrics
The filing text serves as a cover document referencing a press release (Exhibit 99.1) for detailed data. Consequently, this specific text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the attached press release for these figures.
Material Changes
The filing does not contain specific comparative data or descriptions of material changes versus the prior period within the body text. It solely indicates that results for the quarter ended November 27, 2016, have been issued.
Guidance, Outlook, and Risks
The text contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. It explicitly states that the information furnished, including the press release, is not deemed "filed" for purposes of Section 18 of the Exchange Act and shall not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the correct registrant is Landec Corporation, not Lifecore Biomedical, Inc.
- Locate and review Exhibit 99.1 (the press release) to obtain actual financial figures for the quarter ended November 27, 2016.
- Confirm the fiscal year-end date of November 27, 2016, aligns with the company's standard fiscal calendar.
- Note that this 8-K is a notification of results and does not itself contain the detailed financial statements.